ALCAM and VCAM-1 as potential urinary biomarkers in Caucasian lupus patients

被引:0
|
作者
Habazi, Deena [1 ]
Vanarsa, Kamala [1 ]
Stanley, Samantha [1 ]
Gokaraju, Sirisha [1 ]
Ding, Huihua [1 ]
Parodis, Ioannis [2 ]
Gunnarsson, Iva [2 ]
Mohan, Chandra [1 ]
机构
[1] Univ Houston, Houston, TX 77004 USA
[2] Karolinska Inst, Stockholm, Sweden
来源
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
175.17
引用
收藏
页数:3
相关论文
共 50 条
  • [1] URINARY LEVELS OF VCAM-1 AND TWEAK AS BIOMARKERS OF LUPUS NEPHRITIS
    Urrego, T.
    Ortiz-Reyes, B.
    Aroca, G.
    Vanegas-Garcia, A. L.
    Cadena Bonfanti, A. A.
    Almendrales, L.
    Munoz, C. H.
    Gonzalez, L. A.
    Iglesias, A.
    Vasquez, G.
    Gomez-Puerta, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1239 - 1239
  • [2] Urinary Angiostatin, CXCL4 and VCAM-1 As Biomarkers for Lupus Nephritis
    Mok, Chi Chiu
    Soliman, Samar
    Ho, Ling Yin
    Mohan, Chandra
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] URINARY ANGIOSTATIN, CXCL4 AND VCAM-1 AS BIOMARKERS FOR LUPUS NEPHRITIS
    Mok, C. C.
    Soliman, S.
    Ho, L. Y.
    Mohamed, F.
    Mohammed, F. I.
    Mohan, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 583 - 583
  • [4] Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
    Mok, Chi Chiu
    Soliman, Samar
    Ho, Ling Yin
    Mohamed, Fatma A.
    Mohamed, Faten Ismail
    Mohan, Chandra
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [5] Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
    Chi Chiu Mok
    Samar Soliman
    Ling Yin Ho
    Fatma A. Mohamed
    Faten Ismail Mohamed
    Chandra Mohan
    Arthritis Research & Therapy, 20
  • [6] ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus
    Parodis, Ioannis
    Gokaraju, Sirisha
    Zickert, Agneta
    Vanarsa, Kamala
    Zhang, Ting
    Habazi, Deena
    Botto, Joao
    Alves, Clara Serdoura
    Giannopoulos, Panagiotis
    Larsson, Anders
    Svenungsson, Elisabet
    Gunnarsson, Iva
    Mohan, Chandra
    RHEUMATOLOGY, 2020, 59 (09) : 2237 - 2249
  • [7] Urinary VCAM-1 as a biomarker of lupus nephritis disease activity
    Eve Smith
    Rachel Corkhill
    Angela Midgley
    Louise Watson
    Caroline Jones
    Stephen Marks
    Kjell Tullus
    Clarissa Pilkington
    Michael W Beresford
    Pediatric Rheumatology, 12 (Suppl 1)
  • [8] Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer's disease
    Chen, Jian
    Dai, An-Xiang
    Tang, Hai-Liang
    Lu, Chang-Hao
    Liu, Hao-Xin
    Hou, Ting
    Lu, Zhi-Jie
    Kong, Nan
    Peng, Xin-Yuan
    Lin, Kai-Xun
    Zheng, Zi-Dong
    Xu, Sheng-Liang
    Ying, Xiao-Fang
    Ji, Xiao-Yu
    Pan, Hui
    Wu, Jie
    Zeng, Xin
    Wei, Nai-Li
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [9] Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis
    Gasparin, Andrese Aline
    Bueno de Andrade, Nicole Pamplona
    Hax, Vanessa
    Palominos, Penelope Esther
    Siebert, Marina
    Marx, Romulo
    Schaefer, Pedro Guilherme
    Veronese, Francisco Verissimo
    Monticielo, Odirlei Andre
    BMC RHEUMATOLOGY, 2020, 4 (01)
  • [10] VCAM-1 EXPRESSION IN LUPUS NEPHRITIS AND CRESCENTIC NEPHRITIS
    MA, LJ
    WANG, HY
    KIDNEY INTERNATIONAL, 1995, 48 (02) : 597 - 597